The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only

References

1. 1.↵
   2. Pui CH,
   3. Campana D,
   4. Pei D, et al

   . Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009;360:2730–41 doi:10.1056/NEJMoa0900386 pmid:19553647

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Cheung YT,
   3. Krull KR

   . Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: a systematic review. Neurosci Biobehav Rev 2015;53:108–20 doi:10.1016/j.neubiorev.2015.03.016 pmid:25857254

   CrossRefPubMed
3. 3.↵
   2. Hudson MM,
   3. Ness KK,
   4. Gurney JG, et al

   . Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371–81 doi:10.1001/jama.2013.6296 pmid:23757085

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Sabin ND,
   3. Santucci AK,
   4. Klimo P Jr., et al

   . Incidental detection of late subsequent intracranial neoplasms with magnetic resonance imaging among adult survivors of childhood cancer. J Cancer Surviv 2014;8:329–35 doi:10.1007/s11764-014-0344-8 pmid:24488818

   CrossRefPubMed
5. 5.↵
   2. Krull KR,
   3. Brinkman TM,
   4. Li C, et al

   . Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude Lifetime Cohort study. J Clin Oncol 2013;31:4407–15 doi:10.1200/JCO.2012.48.2315 pmid:24190124

   Abstract/FREE Full Text
6. 6.↵
   2. Bhojwani D,
   3. Sabin ND,
   4. Pei D, et al

   . Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 2014;32:949–59 doi:10.1200/JCO.2013.53.0808 pmid:24550419

   Abstract/FREE Full Text
7. 7.↵
   2. Reddick WE,
   3. Glass JO,
   4. Helton KJ, et al

   . Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol 2005;26:1263–69 pmid:15891195

   Abstract/FREE Full Text
8. 8.↵
   2. Fisher MJ,
   3. Khademian ZP,
   4. Simon EM, et al

   . Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR Am J Neuroradiol 2005;26:1686–89 pmid:16091514

   Abstract/FREE Full Text
9. 9.↵
   2. Choudhri AF,
   3. Chin EM,
   4. Blitz AM, et al

   . Diffusion tensor imaging of cerebral white matter: technique, anatomy, and pathologic patterns. Radiol Clin North Am 2014;52:413–25 doi:10.1016/j.rcl.2013.11.005 pmid:24582347

   CrossRefPubMed
10. 10.↵
    2. Raffin E,
    3. Dyrby TB

    . Diagnostic approach to functional recovery: diffusion-weighted imaging and tractography. Front Neurol Neurosci 2013;32:26–35 doi:10.1159/000348818 pmid:23859960

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Yang E,
    3. Nucifora PG,
    4. Melhem ER

    . Diffusion MR imaging: basic principles. Neuroimaging Clin N Am 2011;21:1–25, vii doi:10.1016/j.nic.2011.02.001 pmid:21477749

    CrossRefPubMed
12. 12.↵
    2. Roberts RM,
    3. Mathias JL,
    4. Rose SE

    . Relationship between diffusion tensor imaging (DTI) findings and cognition following pediatric TBI: a meta-analytic review. Dev Neuropsychol 2016;41:176–200 doi:10.1080/87565641.2016.1186167 pmid:27232263

    CrossRefPubMed
13. 13.↵
    2. Edelmann MN,
    3. Krull KR,
    4. Liu W, et al

    . Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. Brain 2014;137(Pt 11):2973–83 doi:10.1093/brain/awu230 pmid:25125614

    CrossRefPubMed
14. 14.↵
    2. Sidaros A,
    3. Engberg AW,
    4. Sidaros K, et al

    . Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study. Brain 2008;131(Pt 2):559–72 doi:10.1093/brain/awm294 pmid:18083753

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Cheung YT,
    3. Sabin ND,
    4. Reddick WE, et al

    . Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol 2016;3:e456–66 doi:10.1016/S2352-3026(16)30110-7 pmid:27658980

    CrossRefPubMed
16. 16.↵
    2. Krull KR,
    3. Cheung YT,
    4. Liu W, et al

    . Chemotherapy pharmacodynamics and neuroimaging and neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2016;34:2644–53 doi:10.1200/JCO.2015.65.4574 pmid:27269941

    Abstract/FREE Full Text
17. 17.↵
    2. Pui CH,
    3. Relling MV,
    4. Sandlund JT, et al

    . Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol 2004;83(Suppl 1):S124–26 pmid:15124703

    CrossRefPubMed
18. 18.↵
    2. Welker KM,
    3. Patton A

    . Assessment of normal myelination with magnetic resonance imaging. Semin Neurol 2012;32:15–28 doi:10.1055/s-0032-1306382 pmid:22422203

    CrossRefPubMed
19. 19.↵
    2. Delis DC,
    3. Kaplan E,
    4. Kramer JH

    . Delis-Kaplan Executive Function System. San Antonio: Psychological Corporation; 2001
20. 20.↵
    2. Wechsler D

    . Wechsler Abbreviated Scale of Intelligence. San Antonio: Psychological Corporation; 1999
21. 21.↵
    2. Wechsler D

    . Wechsler Intelligence Scale for Children. 4th ed. San Antonio: Harcourt Assessment; 2003
22. 22.↵
    2. Wechsler D

    . Wechsler Adult Intelligence Scale. 4th ed. San Antonio: Pearson; 2008
23. 23.↵
    2. Conners CK

    . Conners' Continuous Performance Test II. North Tonawanda: Multi-Health Systems; 2001
24. 24.↵
    2. Meyers JE,
    3. Meyers KR

    . Rey Complex Figure and Recognition Trial. Odessa: Psychological Assessment Resources; 1996
25. 25.↵
    2. Strauss E,
    3. Sherman EM,
    4. Spreen O

    . A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. New York: Oxford University Press; 2006
26. 26.↵
    2. Duffner PK,
    3. Armstrong FD,
    4. Chen L, et al

    . Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group. J Pediatr Hematol Oncol 2014;36:8–15 doi:10.1097/MPH.0000000000000000 pmid:24345882

    CrossRefPubMed
27. 27.↵
    2. Aukema EJ,
    3. Caan MW,
    4. Oudhuis N, et al

    . White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys 2009;74:837–43 doi:10.1016/j.ijrobp.2008.08.060 pmid:19117694

    CrossRefPubMedWeb of Science
28. 28.↵
    2. ElAlfy M,
    3. Ragab I,
    4. Azab I, et al

    . Neurocognitive outcome and white matter anisotropy in childhood acute lymphoblastic leukemia survivors treated with different protocols. Pediatr Hematol Oncol 2014;31:194–204 doi:10.3109/08880018.2013.871763 pmid:24498883

    CrossRefPubMed
29. 29.↵
    2. Genschaft M,
    3. Huebner T,
    4. Plessow F, et al

    . Impact of chemotherapy for childhood leukemia on brain morphology and function. PLoS One 2013;8:e78599 doi:10.1371/journal.pone.0078599 pmid:24265700

    CrossRefPubMed
30. 30.↵
    2. Khong PL,
    3. Leung LH,
    4. Fung AS, et al

    . White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol 2006;24:884–90 doi:10.1200/JCO.2005.02.4505 pmid:16484697

    Abstract/FREE Full Text
31. 31.↵
    2. Porto L,
    3. Preibisch C,
    4. Hattingen E, et al

    . Voxel-based morphometry and diffusion-tensor MR imaging of the brain in long-term survivors of childhood leukemia. Eur Radiol 2008;18:2691–700 doi:10.1007/s00330-008-1038-2 pmid:18491104

    CrossRefPubMed
32. 32.↵
    2. Schuitema I,
    3. Deprez S,
    4. Van Hecke W, et al

    . Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol 2013;31:3378–88 doi:10.1200/JCO.2012.46.7050 pmid:23960182

    Abstract/FREE Full Text
33. 33.↵
    2. Zou L,
    3. Su L,
    4. Xu J, et al

    . Structural brain alteration in survivors of acute lymphoblastic leukemia with chemotherapy treatment: a voxel-based morphometry and diffusion tensor imaging study. Brain Res 2017;1658:68–72 doi:10.1016/j.brainres.2017.01.017 pmid:28109978

    CrossRefPubMed